Lexeo Therapeutics Appoints Kyle Rasbach as Chief Financial Officer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/13/2026

1. CSCO
2. CBRS
3. COHR
4. SPY
5. STUB
6. EAT
7. BTGO
8. NVDA
9. WYFI
10. ARX

Go back to Lexeo Therapeutics Appoints Kyle Rasbach as Chief Financial Officer
(NASDAQ: LXEO) Delayed: 4.96 +0.09 (1.85%)
Previous Close $4.87    52 Week High $ 
Open $4.95    52 Week Low $ 
Day High $5.02    P/E N/A 
Day Low $4.73    EPS $ 
Volume 1,109,491